This is HOMEinPress Releasespages.

Press Releases

2017

Oct 24, 2017

Summary of Consolidated Financial Results for the First Six Months of the Fi scal Year Ending March 31, 2018.

Oct. 18, 2017

Determined to provide reagents for Australia’s National Bowel Cancer Screening Program [PDF:42KB]

Sep. 14, 2017

Revision of the Financial Forecast for the first six months of fiscal year ending March 31, 2018 [PDF:67KB]

Jul. 26, 2017 Financial Flash Report for the First Quarter of Fiscal Year Ending March 31, 2018
Jul. 26, 2017 Bridge Report for the fiscal year March 2017.
May. 26, 2017 NOTICE OF CONVOCATION OF THE 79th GENERAL MEETING SHAREHOLDERS [PDF:158KB]
Apr. 27, 2017

Financial Flash Report for the Fiscal Year Ended March 31, 2017.

Mar. 14, 2017 Revision of the Financial Forecast for the Fiscal Year Ending March 31, 2017.[PDF:72KB]
Jan. 26, 2017

Financial Flash Report for the First Third Quarters of Fiscal Year Ending March 31, 2017

2016

Oct. 25, 2016

Financial Flash Report for the First Second Quarter of Fiscal Year Ending March 31, 2017.

Aug. 31, 2016

EIKEN CHEMICAL signed a distribution agreement with HUMAN for tuberculosis(TB) and malaria molecular diagnosis system by using LAMP method (LAMP). [PDF:61KB]

Aug. 23, 2016

WHO Recommends Loopamp™ PURE MTBC for Diagnosis of Pulmonary TB [PDF:141KB]

Jul. 26, 2016

Financial Flash Report for the First Quarter of Fiscal Year Ending March 31, 2017

Jul. 24, 2016

Bridge Report for the fiscal year March 2016.

Jun. 22, 2016 NOTICE OF RESOLUTIONS OF THE 78th GENERAL MEETING OF SHAREHOLDERS [PDF:35KB]
May. 26, 2016 NOTICE OF CONVOCATION OF THE 78th GENERAL MEETING SHAREHOLDERS [PDF:180KB]
Apr. 27, 2016

Regarding the Medium-Term Management Plan of Eiken Group [PDF:78KB]

Apr. 27, 2016

Financial Flash Report for the Fiscal Year Ended March 31, 2016.

Jan. 26, 2016

Financial Flash Report for the First Third Quarters of Fiscal Year Ending March 31, 2016

Jan. 8, 2016 Eiken Chemical Enters Business Alliance with Sysmex Corporation in the Field of Urine Chemistry Testing in Overseas Markets [PDF:50KB]

2015

Oct. 23, 2015

Financial Flash Report for the First Second Quarter of Fiscal Year Ending March 31, 2016.

Jul. 24, 2015

Bridge Report for the Fiscal Year Ended March 31, 2015.

Jun. 24, 2015

Bridge Report for the First Second Quarter of Fiscal Year Ending March 31,2015.

Jun. 3, 2015 NOTICE OF CONVOCATION OF THE 77th GENERAL MEETING SHAREHOLDERS [PDF:161KB]
Apr. 27, 2015

Financial Flash Report for the Fiscal Year Ended March 31, 2015.

Jan. 27, 2015 Development of the next-generation compact fully automated genetic testing device and multi-item testing chip, using the LAMP method. [PDF:41KB]
Jan. 27, 2015

Financial Flash Report for the First Third Quarters of Fiscal Year Ending March 31, 2015

2014

Dec. 25, 2014 France adopted a national colorectal cancer screening test [PDF:76KB]
Oct. 23, 2014

Financial Flash Report for the First Second Quarter of Fiscal Year Ending March 31, 2015.

May 22, 2014

Bridge Report for the First Second Quarter of Fiscal Year Ending March 31, 2015.

Apr. 28, 2014

Financial Flash Report for the Fiscal Year Ended March 31, 2014.

Jan. 28, 2014

Financial Flash Report for the First Third Quarters of Fiscal Year Ending March 31, 2014

2013

Dec. 2, 2013

Bridge Report for the First Second Quarter of Fiscal Year Ending March 31,2014.

Oct. 23, 2013

Financial Flash Report for the First Second Quarter of Fiscal Year Ending March 31, 2014.

Jul. 24, 2013

Financial Flash Report for the First Quarter of the Year Ending March 31, 2014.

Apr. 25, 2013

Financial Flash Report for the Fiscal Year Ended March 31, 2013.

Jan. 30, 2013

Financial Flash Report for the First Third Quarters of Fiscal Year Ending March 31, 2013

2012

Oct. 26, 2012

Financial Flash Report for the First Second Quarter of Fiscal Year Ending March 31, 2013.

Jul. 26, 2012

Financial Flash Report for the First Quarter of the Year Ending March 31, 2013.

Apr. 26, 2012

Financial Flash Report for the Year Ended March 31, 2012.

Apr. 19, 2012 Notice of Adjustment to the Forecast of Operating Results.
51KB
Mar. 22, 2012 Eiken Chemical Co., Ltd. and Mast Group Ltd. (United Kingdom) sign Patent License Agreement on the licensing of LAMP technology.
36KB
Jan. 27, 2012

Financial Flash Report for the First Third Quarters of Fiscal Year Ending March 31, 2012.

2011

Oct. 26, 2011

Financial Flash Report for the First Second Quarters of Fiscal Year Ending March 31, 2012.

Sep. 16, 2011 First Field-based Molecular Diagnostic Test for African Sleeping Sickness in Sight.
66KB
Jul. 27, 2011

Financial Flash Report for the First Quarter of the Year Ended March 31, 2012.

Jun. 23, 2011 Announcement Regarding the Establishment of our Company's Office in Europe.
20KB
May 26, 2011 Release of the “Loopamp® Tuberculosis Complex Detection Reagent Kit”, a pharmaceutical for in vitro diagnosis, as well as the “Loopamp® PURE DNA Extraction Kit”, “Loopamp® LF-160 Homeothermal Equipment with Fluorometer” and “PureLAMPTM Heater”.
69KB
May 17, 2011 Eiken Chemical Co., Ltd. and Sydney Water Corporation (Australia) signed License Agreement on the licensing of LAMP technology.
26KB
Apr. 27, 2011

Financial Flash Report for the Year Ended March 31, 2011.

Mar. 31, 2011 Eiken Chemical Co., Ltd. and OptiGene Limited (United Kingdom) signed License Agreement on the licensing of LAMP technology.
33KB
Mar. 29, 2011 Eiken Chemical Co., Ltd. and Veterinary Laboratories Agency (VLA, United Kingdom) signed License Agreement on the licensing of LAMP technology.
12KB
Mar. 15, 2011 Notice regarding the Affect of the Pacific Coast of Tohoku Earthquake.
12KB

2010

Dec. 17, 2010 Eiken Chemical Co., Ltd. and 3M sign Patent License Agreement on the licensing of LAMP technology.
11KB
Oct. 26, 2010

Financial Flash Report for the Second Quarter of Fiscal Year Ending March 31, 2011

Apr. 27, 2010

Financial Flash Report for the Year Ended March 31, 2010.

Page Topp

2009

Oct. 27, 2009 New Influenza Virus (AH1pdm 2009)
Information Regarding the Release of the LAMP Primer Set.

11KB
Oct. 27, 2009

Financial Flash Report for the Second Quarter of Fiscal Year Ending March 31, 2010

Jun. 29, 2009 Eiken Chemical Co., Ltd. and Toshiba Corporation Sign License Agreement on Application of LAMP Method for Bioterrorism Monitoring.
38KB
Apr. 27, 2009

Financial Flash Report for the Year Ended March 31, 2009.

Page Top

2008

Oct. 27, 2008 FIND and Eiken Chemical Co., Ltd. announce agreement on further joint efforts, including financial support for LAMP-based TB diagnostics and expansion of their collaboration into HIV, malaria and sleeping sickness.
34KB
Jun. 18, 2008 Launch of "Loopamp Cryptosporidium Detection Kit" and "Loopamp Giardia Detection Kit".
Jan. 24, 2008 Launch of "Loopamp Flavobacterium psychrophilum Primer Set".

Page Top

2007

Dec. 18, 2007 Eiken Chemical Co., Ltd. and DiaSorin S.p.A. (Itlay) signed License Option Agreement on the licensing of LAMP technology 35KB

Page Top

2006

Oct. 25, 2006 Eiken Chemical Co., Ltd. and Meridian Bioscience, Inc. (U.S.A) signed agreement on the licensing of LAMP technology in the medical field for infectious diseases. 35KB
Sep. 7, 2006 Strategic partnership agreement between Eiken Chemical Co., Ltd. and Otsuka Pharmaceutical Co., Ltd. accompanied by the acquisition of a strategic stake in Eiken Chemical Co., Ltd. by Otsuka Pharmaceutical Co., Ltd. 15KB
Mar. 29, 2006 Launch of "Loopamp Campylobacter Detection Kit".

Page Top

2005

Dec. 20, 2005 Strategic partnership agreement between EIKEN CHEMICAL CO., LTD. and Hitachi High-Technologies Corporation accompanied by the acquisition of a strategic stake in EIKEN CHEMICAL CO., LTD. by Hitachi High-Technologies Corporation
Nov. 21, 2005 Launch of "Loopamp Norovirus GI Detection Kit" and "Loopamp Norovirus GII Detection Kit".
Oct. 11, 2005 EIKEN obtained ISO13485:2003 and ISO9001:2000 certification.
Sep. 14, 2005 Launch of "Loopamp L. monocytogenes Detection Kit".
Jul. 29, 2005 The Foundation for Innovative New Diagnostics (FIND) and Eiken Chemical Co., Ltd. Announce Collaboration to Develop Rapid Diagnostic Test for Tuberculosis. 33KB
Jun. 23, 2005 Launch of "Loopamp O157 Detection Kit".
Jun. 20, 2005 Launch of "Loopamp Avian Flu H7 Primer Set".
Jun. 14, 2005 Launch of "Loopamp A.acidoterrestris Primer Set".
Mar. 15, 2005 Launch of "Loopamp Koi Herpesvirus Primer Set".

Page Top

2004

Dec. 21, 2004 Launch of "Loopamp Avian Flu H5 Primer Set". 9KB
Dec. 17, 2004 Launch of "Loopamp P450 Typing Kit".
Nov. 10, 2004 EIKEN acquired FDA approval for FOBT reagent and analyzer, which are now on sale. 11KB
Sep. 21, 2004 Development of novel automaded urine analyzer "US-1000".
Sep. 15, 2004 EIKEN enters into joint research with Kobe Institute of Health for the development of Mycobacterium tuberculosis Complex detection reagent using LAMP method.
Sep. 7, 2004 The research on ubiquitous POCT (point of care testing) device for infections diseases detection basing on LAMP method was adopted by JST.
Aug. 26, 2004 Launch of "Centrifugal machine EC-10" and "Blood collecting set 'Eiken'" for a mailing medical checkup.
Jul. 26, 2004 Launch of "Loopamp West Nile Virus Primer Set". 9KB
Jun. 23, 2004 Launch of "Loopamp RNA Amplification Kit (RT-LAMP)" .
Jun. 21, 2004 EIKEN successfully developed a simple, sensitive, rapid and novel type of microchip technology basing on LAMP method.
May 11, 2004 The development for koi herpesvirus disagnostic and detection method using LAMP method was adopted by the Research project for utilizing advanced technologies in agriculture, forestry and fisheries.
Mar. 25, 2004 EIKEN and National Institute of Infectious Diseases successfully developed highly pathogenic avian influenza virus detection reagent using LAMP method.
Mar. 22, 2004 Launch of "Loopamp Legionella Screening Kit E" for environmental detection.

Page Top

2003

Dec. 18, 2003 Launches of "Loopamp SARS-CoV Detection Kit". 57KB
Jul. 9, 2003 EIKEN entering into joint research project with SAPPORO BREWERIES for the development of process check system of beer manufacture using LAMP method.
Jun. 25, 2003 Agreement with FUJIHIRA INDUSTRY on the distribution of Loopamp Bovine Embryo Sexing Kit in China.
Jun. 23, 2003 Licensing to MORITEX of LAMP patents for Turbidimeter.
Jun. 19, 2003 EIKEN entering into joint research project with Nagasaki University, Institute of Tropical Medicine for the development of SARS corona virus detection reagent using LAMP method.
Jun. 18, 2003 Licensing to Shanghai Fudan-Zhangjiang Bio-Pharmaceutical of LAMP patents for detection of microorganisms.
Mar. 27, 2003 Launch of novel Loopamp Salmonella Screening Kit, Loopamp Verotoxin-producing Escherichia coli Screening Kit, and Loopamp Verotoxin Typing Kit.
Feb. 26, 2003 Licensing to SHIMADZU CORPORATION of LAMP patents for detection of Johne's Bacillus.
Jan. 30, 2003 Licensing to NIPPON GENE of LAMP patents for use in genetic modification within the food industry.

Page Top

2002

Oct. 10, 2002 Licensing to JA WAKAYAMA of LAMP patents for horticultural industry (plant viruses).
Sep. 18, 2002 Launch of Real Time Turbidimeter.
Sep. 17, 2002 Field test in China of Loopamp Bovine Embryo Sexing Kit.
Sep. 5, 2002 Launch of novel Lumispot ‘Eiken’ HCV antigen.
May 21, 2002 LAMP method granted patent in Japan.
May 16, 2002 Launch of Loopamp DNA Amplification Kit by “LAMP”, and servicing of the LAMP Primer design support software.
Mar. 26, 2002 Launch of novel Loopamp Bovine Embryo Sexing Kit and its End Point Turbidimeter.
Mar. 14, 2002 U.S. Patent Issued shortly for Innovative Process for Sythesizing Nucleic Acid “LAMP”.
Mar. 1, 2002 Stocks listed on the first section of the Tokyo Stock Exchange.